Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma
Anna Barata, Aasha I. Hoogland, Anuhya Kommalapati, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 7, pp. 401.e1-401.e7
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration
Margaret A. Park, Christopher J. Whelan, Sabeen Ahmed, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2364-2364
Open Access | Times Cited: 6
Long-Term Cognitive Outcomes in Adult Patients Receiving Chimeric Antigen Receptor T-Cell Therapies
Anna Barata, P. Connor Johnson, Tejaswini Dhawale, et al.
Transplantation and Cellular Therapy (2025)
Closed Access
Cancer-related cognitive impairment in patients with hematologic malignancies after CAR T cell therapy: a systematic review and meta-analysis of prevalence
Mu‐Hsing Ho, Denise Shuk Ting Cheung, Tongyao Wang, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 4
Open Access
Neurotoxic complications of chimeric antigen receptor (CAR) T-cell therapy
Frederick W. Vonberg, Imran Riaz Malik, Maeve O’Reilly, et al.
Journal of Neurology Neurosurgery & Psychiatry (2025), pp. jnnp-333924
Closed Access
Cognitive Decline in Glioblastoma (GB) Patients with Different Treatment Modalities and Insights on Untreated Cases
Keyvan Ghadimi, Imane Abbas, Alireza Karandish, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 152-152
Open Access
Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review
Fabio Efficace, Laura Cannella, Francesco Sparano, et al.
HemaSphere (2022) Vol. 6, Iss. 12, pp. e802-e802
Open Access | Times Cited: 18
Long‐term survivorship care after CAR‐T cell therapy
Robert Puckrin, Kareem Jamani, Víctor H. Jiménez‐Zepeda
European Journal Of Haematology (2023) Vol. 112, Iss. 1, pp. 41-50
Open Access | Times Cited: 9
Change in Neurocognitive Function in Patients Who Receive CAR-T Cell Therapies: A Steep Hill to Climb
Evlampia Strongyli, Paschalis Evangelidis, Ioanna Sakellari, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 591-591
Open Access | Times Cited: 3
Cognition following chimeric antigen receptor T-cell therapy: A systematic review
Christina Kazzi, Valeriya Kuznetsova, Pakeeran Siriratnam, et al.
Journal of Autoimmunity (2023) Vol. 140, pp. 103126-103126
Open Access | Times Cited: 7
Remission after CAR T‐cell therapy: Do lymphoma patients recover a normal life?
Alya Perthus, Fanny Colin, Émilie Charton, et al.
HemaSphere (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 2
Patient-Reported Outcomes as Interradiographic Predictors of Response in Non–Small Cell Lung Cancer
Ambika S. Bhatt, Matthew B. Schabath, Aasha I. Hoogland, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 16, pp. 3142-3150
Open Access | Times Cited: 4
Health-related quality of life in patients with hematologic malignancies treated with chimeric antigen receptor T-cell therapy: review and current progress
Emmanuelle Tchernonog, Aline Moignet, Amélie Anota, et al.
Haematologica (2024)
Open Access | Times Cited: 1
Neurotoxicity of Cancer Immunotherapies Including CAR T Cell Therapy
Kun-Wei Song, Brian J. Scott, Eudocia Q. Lee
Current Neurology and Neuroscience Reports (2023) Vol. 23, Iss. 12, pp. 827-839
Closed Access | Times Cited: 3
Biobehavioral Implications of Chimeric Antigen Receptor T-cell Therapy: Current State and Future Directions
Mallory Taylor, Angela Steineck, Sheila Lahijani, et al.
Transplantation and Cellular Therapy (2022) Vol. 29, Iss. 1, pp. 19-26
Open Access | Times Cited: 5
Immunotherapy-related cognitive impairment after CAR T cell therapy in mice
Anna C. Geraghty, Lehi Acosta-Alvarez, Maria Caterina Rotiroti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy
Amaris Balitsky, Gregory R. Pond, GA Davies, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Prospective assessment of quality of life and patient-reported toxicities over the first year after CAR T-cell therapy
Aasha I. Hoogland, Anna Barata, Xiaoyin Li, et al.
Transplantation and Cellular Therapy (2024)
Closed Access
Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
Ana Cordeiro, George Durisek, Marjorie Vieira Batista, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Novel Neurocognitive Testing Tool for Early Neurotoxicity Detection Following Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-cell Therapy: A Pilot Study
Arvind Suresh, Heather A. Wishart, Maeen N Arslan, et al.
Clinical Lymphoma Myeloma & Leukemia (2024)
Open Access
Real-World Patient-Reported and Neurocognitive Outcomes in the Year After Axicabtagene Ciloleucel
Aasha I. Hoogland, Xiaoyin Li, Karnav Modi, et al.
Transplantation and Cellular Therapy (2024)
Closed Access
Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy
Philipp Karschnia, Kai Rejeski, Marion Subklewe, et al.
Neurology (2023) Vol. 100, Iss. 14, pp. 687-688
Open Access | Times Cited: 1
Expanding the role of combined immunochemotherapy and immunoradiotherapy in the management of head and neck cancer (Review)
Chun Wei, Xiaojun Lan, Maona Qiu, et al.
Oncology Letters (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 1
Response to: Perceived Cognitive Changes Following Chimeric Antigen Receptor T Cell Therapy in Lymphoma: Perceptual Anticipation?
Anna Barata, Aasha I. Hoogland, Brent J. Small, et al.
Transplantation and Cellular Therapy (2022) Vol. 29, Iss. 1, pp. 65-65
Open Access | Times Cited: 1
Perceived Cognitive Changes following Chimeric Antigen Receptor T Cell Therapy in Lymphoma: Perceptual Anticipation?
Brendan Bryan Jen-Wei Tan, Ling Ling Chan, Eng‐King Tan
Transplantation and Cellular Therapy (2022) Vol. 29, Iss. 1, pp. 64-64
Open Access | Times Cited: 1
Data from Patient-Reported Outcomes as Interradiographic Predictors of Response in Non–Small Cell Lung Cancer
Ambika S. Bhatt, Matthew B. Schabath, Aasha I. Hoogland, et al.
(2023)
Open Access
Page 1 - Next Page

Scroll to top